Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Muscle biopsy and MRI findings in ANO5-related myopathy.
Holm-Yildiz S, Witting N, de Stricker Borch J, Kass K, Khawajazada T, Krag T, Vissing J. Holm-Yildiz S, et al. Muscle Nerve. 2021 Dec;64(6):743-748. doi: 10.1002/mus.27419. Epub 2021 Oct 7. Muscle Nerve. 2021. PMID: 34550615
Permanent muscle weakness in hypokalemic periodic paralysis.
Holm-Yildiz S, Witting N, Dahlqvist J, de Stricker Borch J, Solheim T, Fornander F, Eisum AS, Duno M, Soerensen T, Vissing J. Holm-Yildiz S, et al. Neurology. 2020 Jul 28;95(4):e342-e352. doi: 10.1212/WNL.0000000000009828. Epub 2020 Jun 24. Neurology. 2020. PMID: 32580975
Anoctamin-5 related muscle disease: clinical and genetic findings in a large European cohort.
de Bruyn A, Montagnese F, Holm-Yildiz S, Scharff Poulsen N, Stojkovic T, Behin A, Palmio J, Jokela M, De Bleecker JL, de Visser M, van der Kooi AJ, Ten Dam L, Domínguez González C, Maggi L, Gallone A, Kostera-Pruszczyk A, Macias A, Łusakowska A, Nedkova V, Olive M, Álvarez-Velasco R, Wanschitz J, Paradas C, Mavillard F, Querin G, Fernández-Eulate G, Quinlivan R, Walter MC, Depuydt CE, Udd B, Vissing J, Schoser B, Claeys KG. de Bruyn A, et al. Among authors: holm yildiz s. Brain. 2023 Sep 1;146(9):3800-3815. doi: 10.1093/brain/awad088. Brain. 2023. PMID: 36913258
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study.
Bril V, Drużdż A, Grosskreutz J, Habib AA, Mantegazza R, Sacconi S, Utsugisawa K, Vissing J, Vu T, Boehnlein M, Bozorg A, Gayfieva M, Greve B, Woltering F, Kaminski HJ; MG0003 study team. Bril V, et al. Lancet Neurol. 2023 May;22(5):383-394. doi: 10.1016/S1474-4422(23)00077-7. Lancet Neurol. 2023. PMID: 37059507 Clinical Trial.
Hypokalemic periodic paralysis: a 3-year follow-up study.
Holm-Yildiz S, Krag T, Witting N, Pedersen BS, Dysgaard T, Sloth L, Pedersen J, Kjær R, Kannuberg L, Dahlqvist J, de Stricker Borch J, Solheim T, Fornander F, Eisum AS, Vissing J. Holm-Yildiz S, et al. J Neurol. 2023 Dec;270(12):6057-6063. doi: 10.1007/s00415-023-11964-z. Epub 2023 Sep 1. J Neurol. 2023. PMID: 37656291 Free PMC article.
Humoral immune response to COVID-19 vaccine in patients with myasthenia gravis.
Holm-Yildiz S, Dysgaard T, Krag T, Pedersen BS, Hamm SR, Pérez-Alós L, Hansen CB, Pries-Heje MM, Heftdal LD, Hasselbalch RB, Fogh K, Madsen JR, Frikke-Schmidt R, Hilsted LM, Sørensen E, Ostrowski SR, Bundgaard H, Garred P, Iversen K, Nielsen SD, Vissing J. Holm-Yildiz S, et al. J Neuroimmunol. 2023 Nov 15;384:578215. doi: 10.1016/j.jneuroim.2023.578215. Epub 2023 Sep 28. J Neuroimmunol. 2023. PMID: 37797472 Free article.
17 results